{"organizations": [], "uuid": "2ef8799aa03dfb3f1bd0cc37603a9bd735966e66", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/16/globe-newswire-abcann-announces-resignation-of-founding-director-ken-clement.html", "country": "US", "domain_rank": 767, "title": "ABCann Announces Resignation of Founding Director Ken Clement", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-16T14:00:00.000+02:00", "replies_count": 0, "uuid": "2ef8799aa03dfb3f1bd0cc37603a9bd735966e66"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/16/globe-newswire-abcann-announces-resignation-of-founding-director-ken-clement.html", "ord_in_thread": 0, "title": "ABCann Announces Resignation of Founding Director Ken Clement", "locations": [], "entities": {"persons": [{"name": "frankfur", "sentiment": "negative"}, {"name": "ken clement", "sentiment": "negative"}, {"name": "abcann", "sentiment": "none"}, {"name": "ken", "sentiment": "none"}, {"name": "paul lucas", "sentiment": "none"}], "locations": [{"name": "napanee", "sentiment": "none"}, {"name": "ontario", "sentiment": "none"}, {"name": "health canada", "sentiment": "none"}, {"name": "israel", "sentiment": "none"}, {"name": "australia", "sentiment": "none"}, {"name": "napanee", "sentiment": "none"}, {"name": "germany", "sentiment": "none"}], "organizations": [{"name": "abcann global corporation", "sentiment": "negative"}, {"name": "abcann", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NAPANEE, Ontario, March 16, 2018 (GLOBE NEWSWIRE) -- ABcann Global Corporation (TSXV:ABCN) (Frankfurt:23Q) (OTC:ABCCF) (\" ABcann \" or the \" Company \") announced that Ken Clement, ABcann's founder and director, has resigned from the Board of Directors.\nPaul Lucas, ABcann's Chair, commented, \"On behalf of the Board, we thank Ken for his vision in starting the company and growing it from a start-up organization into a well-funded publicly-traded licensed producer with a bright future. We wish Ken well in his future endeavours.\"\nAbout ABcann:\nABcann holds production and sales licenses from Health Canada. Its flagship facility in Napanee, Ontario contains proprietary plant-growing technology, centred on its specially designed, environmentally-controlled growing chambers. This approach results in the production of pharmaceutical-grade cannabis products.\nThe Company is expanding its cultivation capacity and pursuing partnerships and product development opportunities domestically, as well as in select international markets, such as Germany, Australia and Israel.\nON BEHALF OF THE BOARD OF DIRECTORS\n\"Barry Fishman\"\nBarry Fishman\nCEO and Director\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.\nFor further information, please contact: Barry Fishman (CEO and Director) barry.fishman@abcannglobal.com Michael Bumby (CFO) michael.bumby@abcannglobal.com\nSource:ABcann Global Corporation", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/7c05c142-bec7-4766-93f7-837bb16569a3"], "published": "2018-03-16T14:00:00.000+02:00", "crawled": "2018-03-16T15:30:32.005+02:00", "highlightTitle": ""}